Your browser doesn't support javascript.
loading
Longitudinal studies of putative growth hormone (GH) biomarkers and hematological and steroidal parameters in relation to 2 weeks administration of human recombinant GH.
Sieckmann, Tobias; Elmongy, Hatem; Ericsson, Magnus; Bhuiyan, Hasanuzzaman; Lehtihet, Mikael; Ekström, Lena.
Affiliation
  • Sieckmann T; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Elmongy H; Department of Environmental Science and Analytical Chemistry, Stockholm University, Stockholm, Sweden.
  • Ericsson M; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Bhuiyan H; Doping Control Laboratory, Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
  • Lehtihet M; Department of Environmental Science and Analytical Chemistry, Stockholm University, Stockholm, Sweden.
  • Ekström L; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Drug Test Anal ; 12(6): 711-719, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32115881
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Steroids / Recombinant Proteins / Biomarkers / Human Growth Hormone Type of study: Observational_studies / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Drug Test Anal Journal subject: FARMACOLOGIA Year: 2020 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Steroids / Recombinant Proteins / Biomarkers / Human Growth Hormone Type of study: Observational_studies / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Drug Test Anal Journal subject: FARMACOLOGIA Year: 2020 Type: Article Affiliation country: Sweden